AKT1 and breast carcinoma: showed that GABA-Aα3 could activate the AKT signaling pathway in breast cancer and promote tumor cell migration and invasion, while mRNAs and key enzymes that produce GABA-Aα3 were only expressed in some breast cancer cell lines.